Ironwood pharmaceuticals inc

Major-Pharmaceuticals

IRWD


301 Binney Street
Cambridge , MA 02142

Executive/
Director

Price

  • Last Close
  • $ 4.51
    $ +0.18 4.16 %
    Jan 3, 2025
  • 52-Week High/Low
  • $15.45 - $4.04
  • YTD
  • 1.8%

  • Trading Volume
  • 89,509
  • Market Cap Full
  • $ 704.1M
  • Shares Outstanding
  • 156.1M
    Oct 31, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -5.6% 11.6% 2.9% 9.4% -5% -1.6% 7.9% -15.1% -24% 1.8%
Q2 19.6% 10.7% 35.3% -8.2% 4% 15.1% -8.4% 1.1% -28% -
Q3 21.4% -16.5% -5.4% -21.8% 8% 2.6% -10.2% -9.5% -25.3% -
Q4 -3.7% -8.4% -43.2% 54.2% 26.4% -11.7% 19.6% 23.8% 10.9% -
J F M A M J J A S O N D
2025 1.8% - - - - - - - - - - -
2024 24% -33.5% -7.7% -8.9% -20.4% -1.6% 10.3% -25.3% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -24%32%-2%-31%29%-15%3%6%-8%-61%2%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.08 0.33 -0.29 -0.38 0.02 0.25 0.21 0.25
Q2 0.16 0.28 -0.32 0.08 0.16 2.39 0.21 -6.84
Q3 0.18 0.18 -1.14 0.13 0.21 0.34 0.28 0.09
Q4 0.12 0.14 -0.1 0.31 0.27 0.23 0.26 -
A 0.5 0.9 -1.9 0.1 0.7 3.2 1 -6.5

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar 154.6 158.2 161 159.2 154.2
Jun 155.6 159.4 162 153.8 155.3
Sep 156.5 160 162.9 153.2 156
Dec 156.8 160.1 163.7 153.4 156.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - 24 -
Fixed Asset Turnover 58.7 46 17 9.7 5.3
Total Asset Turnover 0.4 0.4 0.7 1.1 1.1
Leverage
Debt Ratio - - - - 0.4
Debt – Equity Ratio - - - - -0.5
Interest Coverage 3.3 -0.8 3.9 1.2 -5.6
Equity multiplier - - 0.4 -0.5 -0.3